Ranibizumab and pegaptanib for the treatment of age-related macular degeneration

Technology appraisal guidance
Reference number: TA155
Published: 27 August 2008
Last updated: 20 May 2024

Appendix A - Decision paper presented to the Institute's Guidance Executive

Appendix A - Decision paper presented to the Institute's Guidance Executive

Appendix A - Decision paper presented to the Institute's Guidance Executive
14 July 2014
(111.86 Kb 32 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 13 July 2014